ArticleIndian pediatrics2026
TeleCARE: An Emerging Tool Leading to Paradigm Shift in the Management of Maintenance Phase of Chemotherapy in Acute Lymphoblastic Leukemia.
Article in Indian pediatrics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
'Teleconsultation Connecting ALL patients in Remote Expanses' (TeleCARE) was introduced to ensure continuity of care for children with acute lymphoblastic leukemia (ALL) during the second wave of the COVID-19 pandemic; consultations were done via phone calls, and reports and prescriptions were shared on WhatsApp. This study reviewed the data of 35 patients with ALL receiving maintenance chemotherapy during the first and second wave of pandemic. 437 telephonic consultations were done over 6 months (73/month). The mean (SD) absolute neutrophil count (ANC, per μL) during teleconsultations was lower than that during physical visits [1754 (461) vs. 2272 (644); P < 0.001], with 55% of patients achieving the target ANC compared to 26% during in-person visits.
Indexed as
Identifiers
41678103What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.